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Abstract  
The severity and frequency of opportunistic fungal infections still growing, 
concomitantly to the increasing rates of antimicrobial drug’s resistance. Natural 
matrices have been used over years due to its multitude of health benefits, including 
antifungal potential. Thus, the present work aims to evaluate the anti-Candida potential 
of the phenolic extract and individual phenolic compounds of Glycyrrhiza glabra L. 
(licorice), by disc diffusion assay, followed by determination of the minimal inhibitory 
concentration (MIC) and minimal fungicidal concentration (MFC) for both planktonic 
cells and biofilms. 
Licorice extract evidenced inhibitory potential against the nineteen tested Candida 
strains, but no pronounced effect was observed by testing the most abundant individual 
phenolic compounds. Candida tropicalis strains were the most sensible, followed by 
Candida glabrata, Candida parapsilosis and, then, Candida albicans. Lower MIC and 
MFC values were achieved to C. glabrata and C. tropicalis, which confirms its 
susceptibility to licorice extract; however, for C. tropicalis strains a higher variability 
was observed. Anti-biofilm potential was also achieved, being most evident in some C. 
glabrata and C. tropicalis strains. In general, a twice concentration of the MIC was 
necessary for planktonic cells to obtain a similar potential to that one observed for 
biofilms. Thus, an upcoming approach for new antifungal agents, more effective and 
safer than the current ones, is stablished; notwithstanding, further studies are necessary 
in order to understand its mechanism of action, as also to assess kinetic parameters. 
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1. Introduction 
Considered as commensal microorganisms, Candida species have been causing a 
multitude of organic disturbances (Martins et al., 2014; Vázquez-González et al., 2013). 
Local infections are the most common, but their frequency and severity, together with 
the increasing rates of systemic infections, alarm the medical community (Mayer et al., 
2013; Wächtler et al., 2012). Numerous antifungal agents were developed, but, 
currently, high rates of inefficacy have been observed (Kanafani and Perfect, 2008; 
Sanglard and Odds, 2002). Despite the mechanisms of acquired-drug resistance are not 
completely understood, several virulence factors have been described as playing an 
important role in the occurrence of the present invasive fungal infection. The ability of 
biofilm formation needs a particular attention, once recent studies showed that the 
majority of Candida infections are associated with biofilm growth (Sardi et al., 2013).  
Natural matrices comprise a multitude of bioactive properties, not only conferred by 
isolated compounds, but mainly due to the occurrence of synergistic and polyvalence 
reactions between them. In particular, phenolic extracts have evidenced significant 
antimicrobial properties against a multitude of opportunistic invaders, including 
Candida species (Barros et al., 2013; Gallucci et al., 2014; Martins et al., 2015b, 
2015c). Glycyrrhiza glabra L. (licorice) is commonly recommended as antitussive, 
mucolytic, expectorant, antiulcer, anti-inflammatory, antimicrobial, cytostatic, 
immunostimulant, and hepatoprotective, as well as flavor enhancer, due to its 
sweetening properties (Vanaclocha and Cañigueral, 2003). Considering the pronounced 
antioxidant activity of the licorice hydromethanolic extract previously reported by the 
authors, mainly attributed to the presence of phenolic compounds such as flavones, 
flavanones and chalcones (Martins et al., 2015a), in the present work, it was 
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investigated the anti-Candida activity of the phenolic extract and individual compounds 
against planktonic cells and biofilms. 
 
2. Materials and Methods 
2.1. Plant material, phenolic extract and individual phenolic compounds 
Rhizomes and roots of G. glabra L., previously dried and reduced in smaller pieces, 
supplied by Soria Natural (Garray – Soria, Spain), were obtained in autumn 2012, after 
reaching three years. The samples were clean products with monitored parameters of 
pesticides, herbicides, heavy metals and radioactivity. 
To obtain the phenolic extract, a hydromethanolic extraction was carried out. The 
sample (1 g) was extracted with 30 mL of methanol: water (80:20, v/v) at 25ºC and 150 
rpm, during 1 h, and then filtered through Whatman No. 4 paper. The obtained residue 
was again extracted with an additional 30 mL portion of the hydromethanolic mixture. 
Both extracts were combined, evaporated at 35ºC under reduced pressure (rotary 
evaporator Büchi R-210, Flawil, Switzerland) and then lyophilized (FreeZone 4.5, Lab- 
conco, Kansas City, MO, USA). The lyophilized extracts were re-dissolved in water, 
performing a stock solution of 50 mg/mL, from which several dilutions were prepared 
to evaluate anti-Candida activity. 
The extract was previously characterized by the authors using HPLC-DAD-ESI/MS 
(Martins et al., 2015a), being formononetin, liquiritigenin and apigenin derivatives the 
most abundant compounds. Therefore, these molecules were also tested (individually 
and combined in the relative proportions found in the extract) for anti-Candida activity, 
after dissolution in water: dimethyl sulfoxide (DMSO) (50:50, v/v), to a stock solution 
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of 1 mg/mL. The same procedure was adopted by using a standard concentration of 1 
mg/mL of each one of the molecules and respective proportional combinations. 
 
2.2. Standards and reagents 
Methanol was of analytical grade purity and supplied by Pronalab (Lisbon, Portugal). 
RPMI 1640 medium and apigenin were purchased from Sigma Chemical Co., (St. 
Louis, MO, USA). Sabouraud Dextrose Broth (SDB) and Agar were from Merck 
(Darmstadt, Germany). Formononetin and liquiritigenin were from Extrasynthese 
(Genay Cedex, France). Water was treated in a Milli-Q water purification system (TGI 
Pure Water Systems, Greenville, SC, USA).   
 
2.3. Evaluation of the anti-Candida activity 
2.3.1. Disc diffusion assay 
Nineteen Candida strains were used during this study (Table 1), belonging to the 
Candida albicans, Candida glabrata, Candida parapsilosis and Candida tropicalis 
species. Four of them were from the American Type Culture Collection (ATCC), and 
the others fifteen were clinical isolates from vaginal and urinary tracts and oral cavity. 
The clinical isolates were obtained from the archive collection of the biofilm group of 
the Centre of Biological Engineering, University of Minho, Braga – Portugal. Before 
each experiment, all strains were grown in Sabouraud Dextrose Agar (SDA) for 24 h at 
37ºC. After that time, one loop of each colony of cells was transferred to Sabouraud 
Dextrose Broth (SDB) and incubated under stirring at 37ºC during 24 h. An aliquot of 
each species (300 µL), containing approximately 1×105 cells/mL was spread in SDA 
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Petri dishes. Then, an aliquot (25 µL) of the licorice extract, with a known concentration 
(50 mg/mL), was placed on a sterile blank disc, previously placed on the inoculated 
petri dishes. Sterile water was used as negative control. The plates were incubated at 
37ºC, during 24–48 h. The evaluation of inhibitory properties was performed measuring 
the corresponding zones of inhibition (mm). 
 
2.3.2. Minimal inhibitory (MIC) and minimal fungicidal (MFC) concentrations  
Minimal inhibitory (MIC) and minimal fungicidal (MFC) concentrations of the licorice 
extract, in planktonic cells was determined based on the guidelines from the Nature 
Protocols (Wiegand et al., 2008), with some modifications. Only the Candida species in 
which pronounced results were reached in the disc diffusion assay, were selected to 
determine MIC and MFC values. Afterwards, a colony recovered from the SDA was 
suspended in 5 mL of sterile saline solution (0.85% NaCl) and vortexed for 15 s. The 
resulting suspension was adjusted by adding saline solution to reach the value of 0.5 in 
McFarland scale. Successive dilutions of the plant extract (0.1875, 0.375, 0.75, and 1.5 
mg/mL) were prepared in RPMI 1640 medium, at pH 7. An aliquot of licorice extract 
(100 µL) was dispensed into a 96-well plates (Orange Scientific, Braine-l’Alleud, 
Belgium) and further incubated with aliquots (100 µL) of the selected Candida species. 
Sample- and yeast- free controls were also included. The 96-well plates were incubated 
at 37ºC for 48 h. After visualization of the resultant plate, the MIC values were 
determined, corresponding to the lower concentration of antifungal agent in which no 
visible growth was observed, by comparison with the control (cells grown without 
extracts). The number of viable cells was assessed by the determination of number of 
colony forming units (CFUs), through several dilutions. After 24 h of incubation at 
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37ºC, the number of colonies formed was counted. The MFC values were considered 
the antifungal agent concentration in which no CFUs were counted. The experiment was 
repeated in triplicate in three independent occasions, and the results presented as the 
total of CFUs (Log CFUs). 
 
2.3.3. Individual phenolic compounds activity 
The evaluation of the anti-Candida potential of individual phenolic compounds was 
carried out using the disc diffusion assay. Sterile water was used as negative control and 
licorice extract (50 mg/mL) as positive control, from which relative proportions of the 
most abundant phenolic compounds, formononetin (F), liquiritigenin (L) and apigenin 
(A), were tested. At the same time, a standard concentration (1 mg/mL) of each one of 
those phenolic compounds was also used to assess the existence of dose-dependent anti-
Candida activity. All the possible combinations of the compounds (F+L; F+A; L+A; 
F+L+A) were also evaluated, considering their relative abundances in the licorice 
extract (Martins et al., 2015a), in order to assess the occurrence of synergistic reactions.  
 
2.4. Effect on biofilm formation 
The effect of licorice hydromethanolic extract against Candida biofilms was only 
determined for the strains in which positive results in planktonic cells were achieved. A 
standardized cell suspension (200 µL containing 1x105 cells/mL in RPMI 1640 
medium) was placed into 96-wells polystyrene microtiter plates and incubated at 37ºC 
on a shaker at 120 rpm/min, during 24 h. Sample and yeast-free controls were also 
included. 
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Then, biofilm medium was aspirated and non-adherent cells were removed by washing 
the biofilms with 200 µL of PBS. 200 µL of each tested concentration of licorice 
hydromethanolic extract (0.75; 1.5; 3 mg/mL) was added. The biofilms were further 
incubated during 24 h, at 37ºC on a shaker at 120 rpm/min. The effect of licorice extract 
on biofilm formation was assessed through quantification of the number o CFUs. These 
experiments were performed in triplicate, in three different occasions, and the results 
presented in terms of Log (CFU). 
 
2.5. Statistical analysis  
Three samples were used for each preparation and all the assays were carried out in 
triplicate. The results were analyzed using one-way analysis of variance (ANOVA) and 
means were compared using Tukey’s honestly significant difference (HSD) multiple 
comparisons test, and further coupled to Welch to verify the equality of means. In the 
case of the graphs of Candida tropicalis, a Student´s t-test was used to determine the 
significant difference among two different samples, with α = 0.05. This treatment was 
carried out using SPSS v. 22.0 program (IBM Corp., Armonk, NY, USA). 
 
3. Results and discussion 
Table 1 shows the anti-Candida potential of licorice extract evaluated by disc diffusion 
assay. Considering the inhibition zones, among the tested Candida species, C. tropicalis 
appeared to be the most susceptible (10-13 mm), followed by C. glabrata (12 mm), C. 
parapsilosis (10-12 mm) and C. albicans (10-12 mm). Karomi et al., (2012), evaluated 
the antifungal potential of different parts of licorice methanolic extract against C. 
albicans, and obtained similar inhibition zones when compared with the present 
experiment. The authors also observed that the antifungal potential was dose-dependent 
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to the licorice concentration, as well as to the type of plant part used: the roots 
evidenced the most pronounced anti-C. albicans potential, followed by stems, leaves 
and then seeds (Karomi et al., 2012). In the same line, Irani et al., (2010) evaluated the 
antimicrobial potential of licorice ethanolic and aqueous extracts, and also achieved 
similar results. Those authors observed an antimicrobial potential, including against C. 
albicans, dependent on the tested concentration, on the type of plant part and on the 
solvent extract used. Once again, the roots of licorice presented a most pronounced 
effect than leaves, and aqueous extract was most effective against C. albicans than 
ethanolic extract. All these results were in part confirmed in the present work and by the 
subsequent determination of MICs and MFCs values.  
Despite in the initial screening (disc diffusion assay), C. tropicalis and C. glabrata 
presented a higher susceptibility to the licorice extract, through using microdillution 
method, the most pronounced sensibility was observed to C. glabrata strains, confirmed 
by the lower MIC and MFC values, which varied, respectively, between 0.1875-0.75 
mg/mL and 0.375-1.5 mg/mL. C. glabrata D1 (MIC=0.1875-0.375 mg/mL; 
MFC=0.375 mg/mL) was the most sensible, followed by 513100 (MIC=0.375-0.75 
mg/mL; MFC=0.75 mg/mL) and ATCC2001 (MIC=0.375-075 mg/mL; MFC=1.5 
mg/mL). Notwithstanding, C. tropicalis also showed a significant susceptibility to 
licorice extract, but a higher variability between tested strains was observed: AG1 and 
T2.2 were the most sensible (MIC=0.375 mg/mL; MFC=0.75 mg/mL), followed by 75 
(MIC=0.375-0.75 mg/mL; MFC=1.5 mg/mL), ATCC750, 12 and 519468 (MIC=0.75-
1.5 mg/mL; MFC=1.5 mg/mL) and, lastly, to 544123, no activity was observed in 
planktonic cells. Among the C. parapsilosis strains, only the reference strain 
ATCC22019 evidenced to be susceptibility (MIC=1.5 mg/mL), but no fungicidal effect 
was achieved at the tested concentrations (0.1875; 0.375; 0.75; 1.5 mg/mL). To the C. 
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albicans strains no antifungal effect was observed. In contrary, Irani et al., (2010) 
detected activity in C. albicans (on both MIC and MFC). Notwithstanding, the tested 
concentrations were higher than the used in the present work, excepting to the licorice 
leaves (MIC/MBC=0.625 mg/mL) and roots (MIC=1.25 mg/mL; MBC=2.5 mg/mL) 
derived from the aqueous extract. Extrapolating these results to the present experiment, 
in which a relative proportion of methanol: water (80:20, v/v) was used, it is possible to 
infer that the active constituents of the licorice extract present a higher solubility in 
water, than using other solvent extracts.  
In relation to the evaluation of the anti-Candida potential of the individual phenolic 
compounds (apigenin, formononetin, liquiritigenin) no pronounced effects were 
achieved, neither at the relative concentration present in the licorice extract (50 mg/mL), 
nor at higher concentrations - 1 mg/mL of each molecule, and respective combinations 
(data no shown). Fatima et al., (2009) evaluated the antifungal potential of ethanol 
extract and ethyl acetate fraction of licorice roots, and an active constituent of this plant 
part, glabridin, against wild type, resistant mutants and clinical isolates of Candida 
species. Glabridin showed pronounced anti-Candida effects: the inhibition zones varied 
between 4-9 mm for the wild type and resistant mutants, and between 6-8 mm for the 
clinical isolates. MIC values were also determined for the present strains, being for the 
wild type and resistant mutants 0.03125-0.125 mg/mL, and for the clinical isolates 
0.0625-0.125 mg/mL. It is very important to highlight that, despite glabridin belongs to 
the class of isoflavonoids, being an isoflavane, the type of solvent extract used highly 
affects the type and quantity of phenolic compounds present in the final extract.  
For the Candida strains in which considerable antifungal effect were observed, the 
effect on biofilm formation was carried out, namely to C. glabrata strains (ATCC2001, 
D1 and 513100) and C. tropicalis (ATCC750 and T2.2). Despite C. tropicalis strains, 
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namely AG1 and T2.2, as well as ATCC750, 12 and 519468 have evidenced a similar 
response to the extract, a representative strain of each group was selected. Figure 1 
shows the obtained results by using licorice extract against biofilms of C. glabrata and 
C. tropicalis, expressed as logarithm of number of CFUs. In general, a twice 
concentration of licorice extract was necessary towards to obtain a similar antifungal 
effect in biofilms. For C. glabrata ATCC2001, the MFC value for planktonic cells was 
1.5 mg/mL, while for biofilms was 3 mg/mL; in the same line, to D1 the obtained MFC 
values in planktonic cells and biofilms were, respectively, 0.375 mg/mL and 3 mg/mL. 
Lastly, for 513100 the MFC values in planktonic cells and biofilms were 0.75 mg/mL 
and 3 mg/mL, respectively. Concerning to C. tropicalis, the obtained MFC values for 
ATCC750 strain were, respectively, 1.5 mg/mL and 3 mg/mL in planktonic cells and 
biofilms. On the other hand, while the obtained MFC value in T2.2 planktonic cells was 
0.75 mg/mL, no MFC value was determined in biofilms, since it was higher than 3 
mg/mL.  
 
4. Conclusions 
Considering all the obtained results, it is possible to conclude that despite some 
Candida strains appears to be sensible to the licorice extract, by using disc diffusion 
assay, similar results and sensibility were not achieved through the determination of 
MIC and MFC, in planktonic cell and biofilms. Furthermore, and despite phenolic 
extract evidenced a promissory anti-Candida potential, no positive effects were 
obtained by using the most abundant individual phenolic compounds, which means that 
probably vestigial molecules improve the final effect of the extract and/or activate some 
of the active constituents.  
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In this sense, further experiments are necessary towards to determine the real 
mechanism of action of the present plant extract, to evaluate the type of lesion caused in 
Candida species, as also to assess kinetic parameters. This would open perspectives 
regarding new antifungal agents, much more effective and safer than the currently 
available.  
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Table 1. Anti-Candida activity of the hydroalcoholic extract from licorice, in 
planktonic cells 
  
Species Strains Origin Inhibition zone (mm) MIC (mg/mL) MFC (mg/mL) 
C. albicans ATCC 90028 Reference 10 >1.5 >1.5 
558234 Vaginal 11 >1.5 >1.5 
575541 Urinary 12 >1.5 >1.5 
557834 Vaginal 11 >1.5 >1.5 
C. glabrata ATCC 2001 Reference 12 0.375-0.75 1.5 
D1 Oral 12 0.1875-0.375 0.375 
513100 Urinary 12 0.375-0.75 0.75 
C. parapsilosis ATCC 22019 Reference 12 1.5 >1.5 
AM2 Oral 10 >1.5 >1.5 
AD Oral 10 >1.5 >1.5 
513143 Vaginal 12 >1.5 >1.5 
491861 Vaginal 12 >1.5 >1.5 
C. tropicalis ATCC 750 Reference 10 0.75-1.5 1.5 
AG1 Oral 10 0.375 0.75 
75 Vaginal 10 0.375-0.75 1.5 
12 Vaginal 10 0.75-1.5 1.5 
544123 Urinary 13 >1.5 >1.5 
519468 Urinary 10 0.75-1.5 1.5 
T2.2 Oral 12 0.375 0.75 
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Figure captions 
Figure 1. Logarithm of number of colony forming units (CFUs) of different C. glabrata 
(A) and C. tropicalis (B) biofilms treated within different concentrations of the 
hydromethanolic extract of licorice. Error bars represent standard deviations (SD). 
**P<0.05 and ***P<0.005, extract concentrations results that are significantly different 
fom the positive control. In each strain different letters mean significant differences 
(p<0.05). 
